Advertisement

Topics

Evotec AG Evotec AG Company Profile

16:12 EDT 18th August 2018 | BioPortfolio

Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. We operate worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic to meet the industry's need for innovation and efficiency in drug discovery (EVT Execute). The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology and infectious diseases. On this basis, Evotec has built a broad and deep pipeline of more than 80 partnered product opportunities at clinical, pre-clinical and discovery stages (EVT Innovate). Evotec has established multiple long-term discovery alliances with partners including Bayer, CHDI, Sanofi or UCB and development partnerships with e.g. with Sanofi in the field of diabetes, with Pfizer in the field of tissue fibrosis and Celgene in the field of neurodegenerative diseases. For additional information please go to www.evotec.com and follow us on Twitter @EvotecAG.


News Articles [614 Associated News Articles listed on BioPortfolio]

Evotec: Der nächste große Deal

Das Wirkstoffforschungsunternehmen Evotec übernimmt ein 100-köpfiges Forscherteam des Pharmakonzerns Sanofi. Man habe eine verbindlichen Vereinbarung unterzeichnet, in deren Rahmen Evotec die Antii....

Evotec: Besteht eine Abwärtsgefahr?

Die Analysten von Berenberg bestätigen die Halteempfehlung für die Aktien von Evotec. Das Kursziel für die Papiere von Evotec sehen die Experten in ihrer aktuellen Analyse weiter bei 14,00 Euro. An...

Bayer zahlt Millionen an Evotec - Gewinne voraus bei Evotec Aktie?

Seit 2012 besteht bereits die Kooperation zwischen der Bayer AG und der Evotec AG. Jetzt zahlt Bayer nochmals vier Millionen Euro an Evotec. Grund hierfür ist eine vielversprechende niedermolekular.....

Evotec: Chance von 104 Prozent

Die in Hamburg ansässige Evotec erforscht und entwickelt Wirkstoffe für pharmazeutische Produkte. Dabei profitiert Evotec vom Trend zum Outsourcing. Denn viele Pharma-Riesen lagern die Wirkstofffor....

Evotec: Kurs unter Druck - Vorschau auf die Zahlen

Die Analysten von Oddo BHF bestätigen die Kaufempfehlung für die Aktien von Evotec. Das Kursziel für die Papiere von Evotec sehen die Experten in ihrer aktuellen Studie wie zuvor bei 22,00 Euro. Di...

Evotec: Schnäppchenjäger aufgepasst!

Evotec im FokusNachdem die Evotec-Aktie in den vergangenen zwei Jahren nur den Weg steil nach oben kannte (2016: +79,8%; 2017: +81,7%), zeigt sich das Papier des Biotech-Spezialisten in der jüngste.....

Evotec receives € 3 million payment from Sanofi

Evotec AG announced that its strategic alliance (TargetBCD) with Sanofi in the field of diabetes has reached its second beta cell therapy milestone, resulting in a payment of € 3 million to Evotec....

EVOTEC und Celgene arbeiten zusammen - EVOTEC-Aktie schiesst hoch

Im Rahmen der Vereinbarung erhält man eine Vorabzahlung in Höhe von 65 Millionen US-Dollar, teilte die Hamburger Firma am späten Montagabend mit. Zudem habe EVOTEC "Anspruch auf potenzielle signifi...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [6 Associated Companies listed on BioPortfolio]

Evotec AG Evotec AG

Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology ...

Evotec

Evotec has considerable technical expertise and manufacturing know-how. Evotec specialise in drug formulation development and the manufacture of clinical trial supplies for biotechnology and pharmaceu...

Evotec AG

Evotec has established itself as the partner of choice for the worlds leading pharmaceutical and biotechnology companies by providing them with high quality, successful and innovative solutions throug...

Evotec AG Media:

Evotec Technologies Inc

The company provides seamless integration of hardware, software and bioware modules, combining cutting-edge technologies for measurement, miniaturisation and automation. EVOscreen®, the high resoluti...

More Information about "Evotec AG Evotec AG" on BioPortfolio

We have published hundreds of Evotec AG Evotec AG news stories on BioPortfolio along with dozens of Evotec AG Evotec AG Clinical Trials and PubMed Articles about Evotec AG Evotec AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Evotec AG Evotec AG Companies in our database. You can also find out about relevant Evotec AG Evotec AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record